PTSD vs Anxiety Disorders — Clinical Trial Comparison
PTSD
Trauma-triggered flashbacks, hypervigilance, and avoidance
Anxiety Disorders
Excessive worry, panic, and physical tension
PTSD and general anxiety disorders share overlapping symptoms — hypervigilance, sleep disturbance, and emotional distress — but they have distinct causes and clinical trial pathways. PTSD trials increasingly focus on trauma processing and psychedelic-assisted therapy, while anxiety trials explore broader anxiolytic approaches. Understanding the difference helps you find the most relevant trials.
Key Differences at a Glance
| Feature | PTSD | Anxiety Disorders |
|---|---|---|
| Primary trigger | Specific traumatic event(s) | No single trauma trigger required |
| Core symptoms | Flashbacks, nightmares, avoidance of trauma cues | Excessive worry, physical tension, avoidance |
| Subtypes | PTSD, complex PTSD, delayed-onset PTSD | GAD, social anxiety, panic disorder, phobias, OCD |
| Severity scoring | PCL-5, CAPS-5 | GAD-7, HAM-A, CGI-S |
| UK prevalence | ~4.4% of adults | ~6.6% of adults (GAD alone) |
| NICE first-line | Trauma-focused CBT or EMDR | CBT + SSRI/SNRI |
Clinical Trial Availability
| Trial Aspect | PTSD | Anxiety Disorders |
|---|---|---|
| UK trials actively recruiting | 20–40 studies | 40–70 studies |
| Most common trial phase | Phase 2–3 | Phase 2–3 |
| Top interventions tested | MDMA-assisted therapy, trauma-focused CBT, EMDR variants, propranolol | SSRIs/SNRIs, CBT delivery formats, neuromodulation, exposure therapy tech |
| Psychedelic trials | MDMA (Phase 3, multiple sites) | Limited (exploratory psilocybin) |
| Digital/app-based trials | Growing (VR exposure, telehealth) | Growing rapidly (app-based CBT) |
| Prevention trials | Post-trauma early intervention | Less common |
Exciting Emerging Treatments
PTSD Trials
- MDMA-assisted therapy — Phase 3 trials showing breakthrough results for severe PTSD
- Virtual reality exposure therapy — immersive trauma processing environments
- Propranolol reconsolidation blockade — weakening traumatic memories during recall
- Stellate ganglion block — local anaesthetic injection showing rapid PTSD relief
- Concussion/TBI-linked PTSD trials — addressing dual pathology
- Digital trauma therapy — app-guided trauma processing with therapist oversight
Anxiety Disorders Trials
- MDMA-assisted therapy — primarily for social anxiety and PTSD
- Virtual reality exposure therapy — for phobias, social anxiety, and agoraphobia
- D-cycloserine augmented CBT — enhancing exposure therapy outcomes
- Neurofeedback — real-time brain activity training for anxiety regulation
- Novel anxiolytics — non-benzodiazepine targeted agents
- App-based interventions — scalable digital mental health trials
💡 Complex PTSD is increasingly recognised in trials
Complex PTSD (C-PTSD), resulting from prolonged or repeated trauma, is now recognised separately in ICD-11. While many PTSD trials accept C-PTSD patients, specific trials targeting complex trauma presentations are emerging. If your symptoms stem from ongoing childhood adversity, domestic abuse, or captivity, look for trials that accept complex trauma histories.
Eligibility Differences
PTSD Trial Criteria
- Documented trauma exposure meeting DSM-5 Criterion A
- Minimum symptom severity on PCL-5 (typically ≥ 33)
- Symptoms present for > 1 month (many trials require > 6 months)
- Some trials specify trauma type (combat, sexual assault, accident)
- Comorbid TBI or substance use may be exclusion or stratification factor
- Current trauma-focused therapy may require washout period
Anxiety Disorders Trial Criteria
- Specific anxiety disorder diagnosis required (GAD, social anxiety, OCD, etc.)
- Severity thresholds vary by disorder (GAD-7 ≥ 10 for GAD trials)
- PTSD as primary diagnosis is usually exclusionary from pure anxiety trials
- OCD trials may require minimum Y-BOCS scores
- Comorbid depression is common and often allowed if secondary
- Benzodiazepine use may be exclusionary due to interaction with study treatments
💭 Anxiety Trials
Find actively recruiting anxiety clinical trials across the UK
View Anxiety Disorders Trials